| Structure |
Chemical Name |
CAS |
MF |
 |
Entinostat |
209783-80-2 |
C21H20N4O3 |
 |
Vorinostat |
149647-78-9 |
C14H20N2O3 |
 |
Sodium 4-phenylbutyrate |
1716-12-7 |
C10H13NaO2 |
 |
Tacedinaline |
112522-64-2 |
C15H15N3O2 |
 |
Panobinostat |
404950-80-7 |
C21H23N3O2 |
 |
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide |
726169-73-9 |
C23H20N6O |
 |
Belinostat (PXD101) |
414864-00-9 |
C15H14N2O4S |
 |
Pracinostat |
929016-96-6 |
C20H30N4O2 |
 |
(1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone |
128517-07-7 |
C24H36N4O6S2 |
 |
MC1568 |
852475-26-4 |
C17H15FN2O3 |
 |
M344 |
251456-60-7 |
C16H25N3O3 |
 |
CUDC-101 |
1012054-59-9 |
C24H26N4O4 |
 |
CRA-02478 |
783355-60-2 |
C21H23N3O5 |
 |
ACY-1215 |
1316214-52-4 |
C24H27N5O3 |
 |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
 |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
 |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
 |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
 |
RGFP 109 |
1215493-56-3 |
C20H25N3O2 |
 |
ITF2357 |
732302-99-7 |
C24H30ClN3O5 |
 |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
 |
Droxinostat |
99873-43-5 |
C11H14ClNO3 |
 |
LMK-235 |
1418033-25-6 |
C15H22N2O4 |
 |
4SC-202 (free base) |
910462-43-0 |
C23H21N5O3S |
 |
RGFP966 |
1396841-57-8 |
C21H19FN4O |
 |
Tubacin |
537049-40-4 |
C41H43N3O7S |
 |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
 |
Tubastatin-A |
1252003-15-8 |
C20H21N3O2 |
 |
CAY10603 |
1045792-66-2 |
C22H30N4O6 |
 |
Nexturastat A |
1403783-31-2 |
C19H23N3O3 |
 |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
 |
CAY10683 (SantacruzaMate A) |
1477949-42-0 |
C15H22N2O3 |
 |
AR-42 |
935881-37-1 |
C18H20N2O3 |
 |
TMP269 |
1314890-29-3 |
C25H21F3N4O3S |
 |
HPOB |
1429651-50-2 |
C17H18N2O4 |
 |
BRD73954 |
1440209-96-0 |
C16H16N2O3 |